Acting CEO
Over 25 years in healthcare company leadership including Genzyme, Acelity and as CEO of Innovative Trauma Care and neoSurgical.
Founder & Scientific Advisor
Professor University of Winnipeg, Adjunct Senior Scientist at CancerCare Manitoba and recognized global expert on NMT and biomarkers.
Chief Scientific Officer
A former Assistant Professor at the University of Winnipeg and an expert on cancer signaling and protein biomarkers.
Chief Medical Officer
Chief, Division of Surgery, University of Utah.
Scientific Advisor
Professor and Director of Medical Oncology & Associate Director, Translational Oncology, University of Illinois.
Scientific Advisor
Chief, Division of Gastroenterology, University of Utah and Huntsman Cancer Institute, Utah.
Board Chair
Angel investor; former lawyer with extensive M&A experience; Director & Board Chair at RocketRez; Director, Valhalla Private Capital; Director, Timia Capital; former Director, Genome Canada.